-+ 0.00%
-+ 0.00%
-+ 0.00%

Is New Michigan R And D Lab Altering The Investment Case For ASICS (TSE:7936)?

Simply Wall St·10/29/2026 20:30:37
语音播报
  • ASICS and the University of Michigan have opened AMSI Lab on the Ann Arbor campus, a US$25 million joint R&D facility focused on translating multidisciplinary sport science into running footwear, apparel, and performance technologies, with researchers, ASICS staff, and athletes working together on real world testing.
  • The AMSI Lab is ASICS' first industry academia innovation center and is linked to its global research network. It creates a structured pipeline that connects university biomechanics, materials science, robotics, and data projects with future product concepts across the running category.
  • The next area of focus is how ASICS' first dedicated US research hub could influence the broader investment narrative around the group.

Scan the next wave of sport science driven opportunities by comparing ASICS' AMSI Lab move with 93 robotics and automation stocks, which is shaping performance and automation across athletics and beyond.

What Is ASICS' Investment Narrative?

To own ASICS stock, you need to buy into a fairly simple idea. This is a global athletic brand that lives or dies on product execution, pricing discipline, and keeping runners loyal across regions like Europe, North America, and Greater China. Earnings and revenue are both forecast to grow around 10% a year, and current net margins of 13.5% plus high return on equity suggest the model can throw off solid profits when demand holds up.

The AMSI Lab fits that story as a long game move rather than a near term catalyst. A US$25 million commitment and a dedicated U.S. research hub add some capital intensity but are small against a ¥942.6b revenue base. The bigger flash points right now sit in a different place. The shares have been volatile, the P/E of 24.8x screens richer than local peers, and the stock has lagged both the JP market and the JP Luxury group over the past year, even as analysts still see upside and view the current price as below fair value.

Still, there is a quieter issue in the background that could matter far more than the new Michigan lab if...

There's only one way to know the right time to buy, sell or hold ASICS. Head to Simply Wall St's company report for the latest analysis of ASICS's Fair Value.

TSE:7936 1-Year Stock Price Chart
TSE:7936 1-Year Stock Price Chart

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community cluster between ¥5,377.88 and ¥5,785, which already shows how far private views on ASICS can spread. These numbers also predate the AMSI Lab announcement, so you now have a fresh R&D catalyst that could shift expectations. Treat this as a prompt to compare multiple viewpoints.

Explore another ASICS fair value estimate, including one that suggests as much as 25% potential upside from the current price.

Decide For Yourself

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Looking For More Ideas Beyond ASICS?

Once you have a view on ASICS, it can help to stack it up against other opportunities that fit very different profiles. Use the Simply Wall St Screener to scan for stocks that match the type of risk, income, or quality tilt you want in your portfolio rather than relying on a single story.